Summary
The Wnt-signaling pathway is a key determinant of cell identity and proliferation. However, when aberrantly activated it drives malignant cell proliferation in gastrointestinal cancer, breast cancer, melanoma and leukemia. The key effector protein of the Wnt pathway is β-catenin, which is continuously degraded in unstimulated cells, but in stimulated cells it accumulates and translocates to the nucleus where it activates transcription. A growing body of literature indicates that transcription factors and co-activators interact through the formation of biomolecular condensates. These are membraneless organelles that concentrate and compartmentalise components through weak, but multivalent interactions. Recently, I have shown that β-catenin forms condensates with Mediator co-activator to specifically activate transcription. However, how this new mode of β-catenin interactions influences the rest of the Wnt-pathway is currently unknown. The overarching goal of this proposal is to uncover how β-catenin condensation impacts the Wnt-signaling pathway. I will investigate the consequences of β-catenin condensation for its cytoplasmic regulation by the destruction complex, study how it affects β-catenin co-factor interactions in the nucleus and determine the effect of oncogenic Wnt-signaling on β-catenin condensates. The proposed work will uncover if β-catenin condensation has a function in the Wnt-signaling pathway outside the nucleus, its effect on co-factor interactions and elucidate how it might contribute to cancer etiology. Deeper understanding of the fundamental Wnt-signaling pathway will have a profound impact on our comprehension of embryonic development, adult regeneration and cancer.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/897220 |
| Start date: | 01-04-2020 |
| End date: | 31-03-2022 |
| Total budget - Public funding: | 187 572,48 Euro - 187 572,00 Euro |
Cordis data
Original description
The Wnt-signaling pathway is a key determinant of cell identity and proliferation. However, when aberrantly activated it drives malignant cell proliferation in gastrointestinal cancer, breast cancer, melanoma and leukemia. The key effector protein of the Wnt pathway is β-catenin, which is continuously degraded in unstimulated cells, but in stimulated cells it accumulates and translocates to the nucleus where it activates transcription. A growing body of literature indicates that transcription factors and co-activators interact through the formation of biomolecular condensates. These are membraneless organelles that concentrate and compartmentalise components through weak, but multivalent interactions. Recently, I have shown that β-catenin forms condensates with Mediator co-activator to specifically activate transcription. However, how this new mode of β-catenin interactions influences the rest of the Wnt-pathway is currently unknown. The overarching goal of this proposal is to uncover how β-catenin condensation impacts the Wnt-signaling pathway. I will investigate the consequences of β-catenin condensation for its cytoplasmic regulation by the destruction complex, study how it affects β-catenin co-factor interactions in the nucleus and determine the effect of oncogenic Wnt-signaling on β-catenin condensates. The proposed work will uncover if β-catenin condensation has a function in the Wnt-signaling pathway outside the nucleus, its effect on co-factor interactions and elucidate how it might contribute to cancer etiology. Deeper understanding of the fundamental Wnt-signaling pathway will have a profound impact on our comprehension of embryonic development, adult regeneration and cancer.Status
CLOSEDCall topic
MSCA-IF-2019Update Date
28-04-2024
Images
No images available.
Geographical location(s)
